Stockreport

Sonoma Pharmaceuticals Announces Results from SebuDerm™ Gel Study in Treatment of Seborrheic Dermatitis

Sonoma Pharmaceuticals, Inc.  (SNOA) 
Last sonoma pharmaceuticals, inc. earnings: 2/14 05:13 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.sonomapharma.com
PDF Evaluation of SebuDerm (hypochlorous acid) Gel on Mild to Moderate Facial and Scalp Seborrheic DermatitisInvestigator Global Assessment (IGA) Scores Showed a 33% Improve [Read more]